Cargando…

Association between human leukocyte antigen and immunosuppressive treatment outcomes in Chinese patients with aplastic anemia

BACKGROUND: Activated cytotoxic T cells (CTLs) recognize the auto-antigens presented on hematopoietic stem/progenitor cells (HSPCs) through class I human leukocyte antigen (HLA) molecules and play an important role in the immune pathogenesis of aplastic anemia (AA). Previous reports demonstrated tha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Lingyun, Ge, Meili, Huo, Jiali, Ren, Xiang, Shao, Yingqi, Li, Xingxin, Huang, Jinbo, Wang, Min, Nie, Neng, Zhang, Jing, Peng, Jin, Zheng, Yizhou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923019/ https://www.ncbi.nlm.nih.gov/pubmed/36793734 http://dx.doi.org/10.3389/fimmu.2023.1056381

Ejemplares similares

Impaired immunosuppressive role of myeloid-derived suppressor cells in acquired aplastic anemia
por: Dong, Peiyuan, et al.
Publicado: (2022)

Impaired immunosuppressive effect of bone marrow mesenchymal stem cell-derived exosomes on T cells in aplastic anemia
por: Wang, Shichong, et al.
Publicado: (2023)

Outcomes of Optimized over Standard Protocol of Rabbit Antithymocyte Globulin for Severe Aplastic Anemia: A Single-Center Experience
por: Li, Xingxin, et al.
Publicado: (2013)

Multifaceted characterization of the signatures and efficacy of mesenchymal stem/stromal cells in acquired aplastic anemia
por: Huo, Jiali, et al.
Publicado: (2020)

A hemizygous p.R204Q mutation in the ALAS2 gene underlies X-linked sideroblastic anemia in an adult Chinese Han man
por: Huang, Jinbo, et al.
Publicado: (2021)

Levamisole Suppresses CD4(+) T-Cell Proliferation and Antigen-Presenting Cell Activation in Aplastic Anemia by Regulating the JAK/STAT and TLR Signaling Pathways
por: Wang, Jiali, et al.
Publicado: (2022)

Increased Bone Marrow (BM) Plasma Level of Soluble CD30 and Correlations with BM Plasma Level of Interferon (IFN)-γ, CD4/CD8 T-Cell Ratio and Disease Severity in Aplastic Anemia
por: Wu, Qingqing, et al.
Publicado: (2014)

Impaired Autophagy in Adult Bone Marrow CD34(+) Cells of Patients with Aplastic Anemia: Possible Pathogenic Significance
por: Huang, Jinbo, et al.
Publicado: (2016)

Comparison of Hematopoietic Stem Cell Transplantation Outcomes Using Matched Sibling Donors, Haploidentical Donors, and Immunosuppressive Therapy for Patients With Acquired Aplastic Anemia
por: Zhang, Yuanfeng, et al.
Publicado: (2022)

Aplastic anemia: immunosuppressive therapy in 2010
por: Risitano, Antonio M., et al.
Publicado: (2011)

Predicting Response of Severe Aplastic Anemia to Rabbit-Antithymocyte Immunoglobulin Based Immunosuppressive Therapy Combined With Eltrombopag
por: Li, Ruixin, et al.
Publicado: (2022)

Immunosuppressive Treatment in Children with Acquired Aplastic Anemia
por: Yıldırmak, Yıldız, et al.
Publicado: (2012)

The novel SLC40A1 (T419I) variant results in a loss-of-function phenotype and may provide insights into the mechanism of large granular lymphocytic leukemia and pure red cell aplasia
por: Wu, Hongfei, et al.
Publicado: (2021)

Immunosuppressive therapy for pediatric aplastic anemia: a North American Pediatric Aplastic Anemia Consortium study
por: Rogers, Zora R., et al.
Publicado: (2019)

Human leukocyte antigen-DRB1 gene polymorphism and aplastic anemia: A meta-analysis
por: Liang, Lijie, et al.
Publicado: (2023)

Comparison of hematopoietic stem cell transplantation and immunosuppressive therapy as the first-line treatment option for patients with severe hepatitis−associated aplastic anemia
por: Zhang, Xiaoyu, et al.
Publicado: (2023)

A unique homozygous WRAP53 Arg298Trp mutation underlies dyskeratosis congenita in a Chinese Han family
por: Shao, Yingqi, et al.
Publicado: (2018)

Predicting response of severe aplastic anemia to immunosuppression combined with eltrombopag
por: Zaimoku, Yoshitaka, et al.
Publicado: (2021)

Efficacy of eltrombopag with immunosuppressive therapy for children with acquired aplastic anemia
por: Zhao, Yufei, et al.
Publicado: (2023)

Aplastic Anemia in China
por: Liu, Chunyan, et al.
Publicado: (2018)

Association of Human Leukocyte Antigen DRB1*15 and DRB1*15:01 Polymorphisms with Response to Immunosuppressive Therapy in Patients with Aplastic Anemia: A Meta-Analysis
por: Liu, Shan, et al.
Publicado: (2016)

Transfusion-dependent non-severe aplastic anemia: characteristics and outcomes in the clinic
por: Zhang, Yawen, et al.
Publicado: (2023)

Thymoma followed by aplastic anemia - two different responses to immunosuppressive therapy
por: de Castro, Murilo Antunes, et al.
Publicado: (2011)

CD106 is a novel mediator of bone marrow mesenchymal stem cells via NF-κB in the bone marrow failure of acquired aplastic anemia
por: Lu, Shihong, et al.
Publicado: (2017)

Traditional Chinese medicine for treating aplastic anemia
por: Guan, Jing, et al.
Publicado: (2023)

Upregulated Expression of Profilin1 on Dendritic Cells in Patients With Severe Aplastic Anemia
por: Yu, Hong, et al.
Publicado: (2021)

Generalized Morphea Coincident With Aplastic Anemia: A Case Report
por: Tapdia, Madhusudan R, et al.
Publicado: (2022)

Efficacy and safety of immunosuppressive therapy in the treatment of seronegative hepatitis associated aplastic anemia
por: Chen, Hai-Fei, et al.
Publicado: (2014)

Immunosuppressive Therapy in Patients with Aplastic Anemia: A Single-Center Retrospective Study
por: Jalaeikhoo, Hasan, et al.
Publicado: (2015)

PB1932: GENERIC ELTHROMBOPAG WITH STANDARD IMMUNOSUPPRESSIVE THERAPY IN SEVERE APLASTIC ANEMIA
por: Ranjit Kumar, C., et al.
Publicado: (2022)

Efficacy of combined immunosuppression with or without eltrombopag in children with newly diagnosed aplastic anemia
por: Goronkova, Olga, et al.
Publicado: (2022)

Upregulated expression of leukocyte immunoglobulin-like receptor A3 in patients with severe aplastic anemia
por: Yu, Hong, et al.
Publicado: (2021)

The Progress of Traditional Chinese Medicine in the Treatment of Aplastic Anemia
por: Zhu, Ningning, et al.
Publicado: (2018)

P796: ENRICHED CD16+ MONOCYTES DRIVE T LYMPHOCYTES CELL RESPONSES IN APLASTIC ANEMIA
por: Ge, M., et al.
Publicado: (2022)

Hematopoietic Stem Cell Regulation by Type I and II Interferons in the Pathogenesis of Acquired Aplastic Anemia
por: Smith, Julianne N. P., et al.
Publicado: (2016)

Immunosuppressive therapy for aplastic anemia: a single-center experience from western India
por: Shah, Sandip, et al.
Publicado: (2018)

Predictive value of T cell receptor repertoire profiling for immunosuppressive therapy in severe aplastic anemia
por: Chen, Cunte, et al.
Publicado: (2023)

Clinical observations on intensive immunosuppressive therapy combined with umbilical cord blood support for the treatment of severe aplastic anemia
por: Zhou, Fang, et al.
Publicado: (2011)

Comparisons Between Frontline Therapy and a Combination of Eltrombopag Plus Immunosuppression Therapy and Human Leukocyte Antigen-Haploidentical Hematopoietic Stem Cell Transplantation in Patients With Severe Aplastic Anemia: A Systematic Review
por: Yang, Yuan, et al.
Publicado: (2021)

Idiopathic severe aplastic anemia with a delayed response to immunosuppressive therapy: a case report
por: Alzahrani, Nujood, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hvnfhsv9483fgsqfh20jn785ti